Prognostic implication of M2 macrophages are determined by the proportional balance of tumor associated macrophages and tumor infiltrating lymphocytes in microsatellite-unstable gastric carcinoma

PLoS ONE

Volumn 10, Issue 12, 2015, Pages

  Kim, Kyung Ju ^a,b   Wen, Xian Yu ^a   Yang, Han Kwang ^a   Kim, Woo Ho ^a   Kang, Gyeong Hoon ^a  

^a Seoul National University College of Medicine   (South Korea)

^b Soonchunhyang University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CD163 ANTIGEN; CD68 ANTIGEN; DNA; CD68 ANTIGEN, HUMAN; CELL SURFACE RECEPTOR; DIFFERENTIATION ANTIGEN; LEUKOCYTE ANTIGEN; MICROSATELLITE DNA;

ADULT; ARTICLE; CELL DENSITY; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DNA EXTRACTION; FEMALE; HISTOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; SCORING SYSTEM; STOMACH CARCINOMA; TISSUE MICROARRAY; TUMOR ASSOCIATED LEUKOCYTE; GENETICS; IMMUNOLOGY; KAPLAN MEIER METHOD; METABOLISM; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; PHYSIOLOGY; PROPORTIONAL HAZARDS MODEL; STOMACH TUMOR;

ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LYMPHOCYTES, TUMOR-INFILTRATING; MACROPHAGES; MALE; MICROSATELLITE REPEATS; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RECEPTORS, CELL SURFACE; STOMACH NEOPLASMS;

EID: 84958064403     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0144192     Document Type: Article

References (40)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010; 127:2893-2917. doi: 10.1002/ijc.25516 PMID: 21351269.
2. Shokal U, Sharma PC. Implication of microsatellite instability in human gastric cancers. Indian J Med Res. 2012; 135:599-613. PMID: 22771588.
3. Choi YY, Bae JM, An JY, Kwon IG, Cho I, Shin HB, et al. Is microsatellite instability a prognostic marker in gastric cancer? A systematic review with meta-analysis. J Surg Oncol. 2014; 110:129-135. doi: 10. 1002/jso.23618 PMID: 24737677.
4. Chiaravalli AM, Feltri M, Bertolini V, Bagnoli E, Furlan D, Cerutti R, et al. Intratumour T cells, their activation status and survival in gastric carcinomas characterised for microsatellite instability and Epstein- Barr virus infection. Virchows Arch. 2006; 448:344-353. PMID: 16261379.
5. Phillips SM, Banerjea A, Feakins R, Li SR, Bustin SA, Dorudi S. Tumour-infiltrating lymphocytes in colorectal cancer with microsatellite instability are activated and cytotoxic. Br J Surg. 2004; 91:469-475. PMID: 15048750.
6. Bauer K, Michel S, Reuschenbach M, Nelius N, von Knebel Doeberitz M, Kloor M, et al. Dendritic cell and macrophage infiltration in microsatellite-unstable and microsatellite-stable colorectal cancer. Fam Cancer. 2011; 10:557-565. doi: 10.1007/s10689-011-9449-7 PMID: 21598004.
7. Biswas SK, Allavena P, Mantovani A. Tumor-associated macrophages: functional diversity, clinical significance, and open questions. Semin Immunopathol. 2013; 35:585-600. doi: 10.1007/s00281-013- 0367-7 PMID: 23657835.
8. Ramanathan S, Jagannathan N. Tumor associated macrophage: A review on the phenotypes, traits and functions. Iran J Cancer Prev. 2014; 7:1-8. PMID: 25250141.
9. Reinartz S, Schumann T, Finkernagel F, Wortmann A, Jansen JM, Meissner W, et al. Mixed-polarization phenotype of ascites-associated macrophages in human ovarian carcinoma: correlation of CD163 expression, cytokine levels and early relapse. Int J Cancer. 2014; 134:32-42. doi: 10.1002/ijc.28335 PMID: 23784932.
10. Tham M, Tan KW, Keeble J, Wang X, Heuber S, Barron L, et al. Melanoma-initiating cells exploit M2 macrophage TGF-beta and arginase pathway for survival and proliferation. Oncotarget. 2014; 5:12027-12042. PMID: 25294815.
11. Kumagai S, Marumo S, Shoji T, Sakuramoto M, Hirai T, Nishimura T, et al. Prognostic impact of preoperative monocyte counts in patients with resected lung adenocarcinoma. Lung Cancer. 2014; 85:457-464.
12. Pei BX, Sun BS, Zhang ZF, Wang AL, Ren P. Interstitial tumor-associated macrophages combined with tumor-derived colony-stimulating factor-1 and interleukin-6, a novel prognostic biomarker in nonsmall cell lung cancer. J Thorac Cardiovasc Surg. 2014; 148:1208-1216.e2. doi: 10.1016/j.jtcvs.2014. 05.003 PMID: 24907005.
13. Kubler K, Ayub TH, Weber SK, Zivanovic O, Abramian A, Keyver-Paik MD, et al. Prognostic significance of tumor-associated macrophages in endometrial adenocarcinoma. Gynecol Oncol. 2014; 135:176-183 doi: 10.1016/j.ygyno.2014.08.028 PMID: 25173585.
14. Zhang Y, Cheng S, Zhang M, Zhen L, Pang D, Zhang Q, et al. High-infiltration of tumor-associated macrophages predicts unfavorable clinical outcome for node-negative breast cancer. PLoS One. 2013; 8: e76-e147. doi: 10.1371/journal.pone.0076147 PMID: 24098773.
15. Yuan ZY, Luo RZ, Peng RJ, Wang SS, Xue C. High infiltration of tumor-associated macrophages in triple- negative breast cancer is associated with a higher risk of distant metastasis. Onco Targets Ther. 2014; 7:1475-1480. doi: 10.2147/OTT.S61838 PMID: 25187727.
16. Behnes CL, Bremmer F, Hemmerlein B, Strauss A, Strobel P, Radzun HJ. Tumor-associated macrophages are involved in tumor progression in papillary renal cell carcinoma. Virchows Arch. 2014; 464:191-196. doi: 10.1007/s00428-013-1523-0 PMID: 24327306.
17. Dannenmann SR, Thielicke J, Stockli M, Matter C, von Boehmer L, Cecconi V, et al. Tumor-associated macrophages subvert T-cell function and correlate with reduced survival in clear cell renal cell carcinoma. Oncoimmunology. 2013; 2:e23562. PMID: 23687622.
18. Edin S, Wikberg ML, Dahlin AM, Rutegard J, Oberg A, Oldenborg PA, et al. The distribution of macrophages with a M1 or M2 phenotype in relation to prognosis and the molecular characteristics of colorectal cancer. PLoS One. 2012; 7:e47045. doi: 10.1371/journal.pone.0047045 PMID: 23077543.
19. Erreni M, Mantovani A, Allavena P. Tumor-associated Macrophages (TAM) and Inflammation in Colorectal Cancer. Cancer Microenviron. 2011; 4:141-154. doi: 10.1007/s12307-010-0052-5 PMID: 21909876.
20. Forssell J, Oberg A, Henriksson ML, Stenling R, Jung A, Palmqvist R, et al. High macrophage infiltration along the tumor front correlates with improved survival in colon cancer. Clin Cancer Res 2007; 13:1472-1479. PMID: 17332291.
21. Wang B, Xu D, Yu X, Ding T, Rao H, Zhan Y, et al. Association of intra-tumoral infiltrating macrophages and regulatory T cells is an independent prognostic factor in gastric cancer after radical resection. Ann Surg Oncol. 2011; 18:2585-2593. doi: 10.1245/s10434-011-1609-3 PMID: 21347781.
22. MacDonald WC, Owen DA, Le L. Chronic advanced gastric cancer: clinicopathologic anlysis of survival daga. Hum Pathol. 2008; 39:641-649. doi: 10.1016/j.humpath.2007.10.003 PMID: 18439937.
23. Zilberstein B, da Costa Martins B, Jacob CE, Bresciani C, Lopasso FP, de Cleva R, et al. Complications of gastrectomy with lymphadenectomy in gastric cancer. Gastric Cancer. 2004; 7: 254-259. PMID: 15616774.
24. Kim KJ, Lee KS, Cho HJ, Kim YH, Yang HK, Kim WH, et al. Prognostic implications of tumor-infiltrating FoxP3+ regulatory T cells and CD8+ cytotoxic T cells in microsatellite-unstable gastric cancers. Hum Pathol. 2014; 45:285-293. doi: 10.1016/j.humpath.2013.09.004 PMID: 24331841.
25. Galon J, Costes A, Sanchez-Cabo F, Kirilovsky A, Mlecnik B, Lagorce-Pages C, et al. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science. 2006; 313:1960-1964. PMID: 17008531.
26. Galon J, Mlecnik B, Bindea G, Angell HK, Berger A, Lagorce C, et al. Towards the introduction of the 'Immunoscore' in the classification of malignant tumours. J Pathol. 2014; 232:199-209. doi: 10.1002/path.4287 PMID: 24122236.
27. Anitei MG, Zeitoun G, Mlecnik B, Marliot F, Haicheur N, Todosi AM, et al. Prognostic and predictive values of the immunoscore in patients with rectal cancer. Clin Cancer Res. 2014; 20:1891-1899. doi: 10. 1158/1078-0432.CCR-13-2830 PMID: 24691640.
28. Yang Li, Wang Fei, Wang Liping, Huang L, Wang J, Zhang B, et al. CD163+ tumor-associated macrophage is a prognostic biomarker and is associated with therapeutic effect on malignant pleural effusion of lung cancer patients. Oncotarget. 2015; 6:10592-10603 PMID: 25871392.
29. Komohara Y, Jinushi M, Takeya M. Clinical significance of macrophage heterogeneity in human malignant tumors. Cancer Sci. 2014; 105:1-8. doi: 10.1111/cas.12314 PMID: 24168081.
30. Wu H, Xu JB, He YL, Peng JJ, Zhang XH, Chen CQ, et al. Tumor-associated macrophages promote angiogenesis and lymphangiogenesis of gastric cancer. J Surg Oncol. 2012; 106:462-468. doi: 10. 1002/jso.23110 PMID: 22488237.
31. Ishigami S, Natsugoe S, Tokuda K, Nakajo A, Okumura H, Matsumoto M, et al. Tumor-associated macrophage (TAM) infiltration in gastric cancer. Anticancer Res. 2003; 23:4079-4083. PMID: 14666722.
32. Zhang H, Wang X, Shen Z, Xu J, Qin J, Sun Y, et al. Infiltration of diametrically polarized macrophages predicts overall survival of patients with gastric cancer after surgical resection. Gastric Cancer. 2014; 18:740-750 doi: 10.1007/s10120-014-0422-7 PMID: 25231913.
33. Nam SJ, Go H, Paik JH, Kim TM, Heo DS, Kim CW, et al. An increase of M2 macrophages predicts poor prognosis in patients with diffuse large B-cell lymphoma treated with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone. Leuk Lymphoma. 2014; 55:2466-2476. doi: 10.3109/10428194.2013.879713 PMID: 24397616.
34. Busuttil RA, George J, Tothill RW, Loculano K, Kowalczyk A, Mitchell C, et al. A signature predicting poor prognosis in gastric and ovarian cancer represents a coordinated macrophage and stroma response. Clin Cancer Res. 2014; 20:2761-2772. doi: 10.1158/1078-0432.CCR-13-3049 PMID: 24658156.
35. Algars A, Irjala H, Vaittinen S, Huhtinen H, Sundstrom J, Salmi M, et al. Type and location of tumor-infiltrating macrophages and lymphatic vessels predict survival of colorectal cancer patients. Int J Cancer. 2012; 131:864-873. doi: 10.1002/ijc.26457 PMID: 21952788.
36. Hernandez C, Barrachina MD, Cosin-Roger J, Ortiz-Masia D, Alvarez A, Terradez L, et al. Progastrin represses the alternative activation of human macrophages and modulates their influence on colon cancer epithelial cells. PLoS One. 2014; 9:e98458. doi: 10.1371/journal.pone.0098458 PMID: 24901518.
37. Subhra K Biswas, Alberto Mantovani. Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm. Nat Immunol. 2010; 11:889-896. doi: 10.1038/ni.1937 PMID: 20856220.
38. Edin S, Wikberg ML, Rutegard J, Oldenborg PA, Palmqvist R. Phenotypic skewing of macrophages in vitro by secreted factors from colorectal cancer cells. PLoS One. 2013; 8:e74982. doi: 10.1371/journal. pone.0074982 PMID: 24058644.
39. Ong SM, Tan YC, Beretta O, Jiang D. Yeap WH, Tai JJ, et al. Macrophages in human colorectal cancer are pro-inflammatory and prime T cells towards an anti-tumour type-1 inflammatory response. Eur J Immunol. 2012; 42:89-100. doi: 10.1002/eji.201141825 PMID: 22009685.
40. Mantovani A, Vecchi A, Allavena P. Pharmacological modulation of monocytes and macrophages. Curr Opin Pharmacol. 2014; 17:38-44.